C. West

发表

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis

J. Ragoussis, A. Harris, C. West, 2011, British Journal of Cancer.

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix

J. Logue, C. West, S. Davidson, 2000, British Journal of Cancer.

Hypoxia-inducible factor-1α expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas

C. West, M. Ebert, H. Valentine, 2006, British Journal of Cancer.

A comet assay of DNA damage and repair in K562 cells after photodynamic therapy using haematoporphyrin derivative, methylene blue and meso-tetrahydroxyphenylchlorin.

J. Moore, B. Marples, C. West, 1997, British Journal of Cancer.

Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy

J. Logue, I. Stratford, C. West, 2000, British Journal of Cancer.

NIMRAD - a phase III trial to investigate the use of nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer.

E. Miles, C. West, N. Slevin, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Gene Expression Signatures as Biomarkers of Tumour Hypoxia.

F. Buffa, C. West, B. Harris, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

The biology of photodynamic therapy.

C. Whitehurst, J. Moore, C. West, 1997, Physics in medicine and biology.

The biology of photodynamic therapy

James V Moore, Catharine M L West, Colin Whitehurst, 1997 .

Is the hypoxia-inducible factor pathway important in gastric cancer?

P. Price, C. West, E. Griffiths, 2005, European journal of cancer.

Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts.

R. Airley, I. Stratford, C. West, 2005, International journal of oncology.

Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predisposition

S. Roberts, C. West, D. Scott, 2002, International journal of radiation biology.

Chromosomal radiosensitivity as a marker of predisposition to common cancers?

S. Roberts, C. West, D. Scott, 2001, British Journal of Cancer.

Detection of Individual Differences in Radiation-Induced Apoptosis of Peripheral Blood Lymphocytes in Normal Individuals, Ataxia Telangiectasia Homozygotes and Heterozygotes, and Breast Cancer Patients after Radiotherapy

A. Kiltie, S. Roberts, C. West, 2000, Radiation research.

A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes.

R. Cowan, D. Scott, C M West, 1995, International journal of radiation biology.

Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours

S. Lunj, C. West, Mechthild Krause, 2024, Frontiers in oncology.

Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity

J. Chang-Claude, F. Wenz, C. West, 2019, Clinical and translational radiation oncology.

Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples

C. Möller-Levet, S. Pepper, C. West, 2011, British Journal of Cancer.

The radiation response of a human colon adenocarcinoma grown in monolayer, as spheroids, and in nude mice.

C. West, R. Sutherland, C. West, 1987, Radiation research.

Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation response.

J. Hendry, C. West, C. West, 1997, International journal of radiation biology.

TORPEdO - A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer.

N. Iles, D. Thomson, Emma Hall, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

University of Birmingham HPV-related oropharyngeal cancer in the United Kingdom

D. McCance, Michael F. Moran, K. Cuschieri, 2016 .

Prognostic significance of c-erb B-2 protein expression in carcinoma of the cervix treated with radiotherapy

J. Hendry, C. West, T. Nishioka, 1999, Journal of Cancer Research and Clinical Oncology.

Head and neck cancer—Part 2: Treatment and prognostic factors

C. Nutting, C. West, H. Mehanna, 2010, BMJ : British Medical Journal.

Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment

J. E. Scaife, R. Jena, N. Burnet, 2015, The British journal of radiology.

Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study

P. Golusiński, H. Mehanna, S. Thavaraj, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Petra Seibold, Hubert Thierens, Alison M Dunning, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.

J. Chang-Claude, J. Debus, A. Dunning, 2015, International journal of radiation oncology, biology, physics.

A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy

J Chang-Claude, N G Burnet, J. Chang-Claude, 2012, British Journal of Cancer.

Association between rheumatoid arthritis and risk of radiotherapy toxicity: a systematic review

C. West, Sarah L. Kerns, Nina Liebenberg, 2024, BMJ Oncology.

Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity.

S. Kerns, G. Barnett, D. Noble, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiogenomics A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity

M. Sydes, A. Dunning, K. Michailidou, 2022 .

Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy.

C. West, C. West, 1995, The British journal of radiology.

Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study

K. D. Sørensen, C. Ulrich, D. Bishop, 2023, medRxiv.

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial

H. Denley, B. Lane, N. Porta, 2024, EBioMedicine.

Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix.

J P Logue, Asha D. Luthra, Andrew P Jones, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Expression of hypoxia-inducible factor 1α in thyroid carcinomas

G. Brabant, C. West, K. Williams, 2010, Endocrine-related cancer.

The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.

C. West, J. Homer, C. Douglas, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer Patients.

P. Seibold, D. Ruysscher, B. Rosenstein, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).